Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Faq

how to run tesamorelin: Frequently asked questions

Source-derived answers connected to this topic.

6 total records
Questions and answers

Frequently asked questions

What If You Miss a Scheduled Tesamorelin Injection?

Administer the missed dose as soon as you remember if fewer than 12 hours have passed. If more than 12 hours late, skip the missed dose and resume your normal schedule the next morning. Do not double-dose to compensate. Missing 2–3 doses per month does not significantly impact overall cycle efficacy, but inconsistent timing (injecting at different times daily) disrupts circadian synchronisation and reduces peak GH response by 20–30%.

View source ↗
What If I Accidentally Left My Reconstituted Tesamorelin at Room Temperature Overnight?

Discard it. Tesamorelin's half-life at room temperature (20–25°C) is approximately 26 minutes in solution. An 8-hour exposure at ambient temperature denatures the peptide structure entirely, rendering it biologically inactive. You cannot visually assess potency loss (the solution will still appear clear), and attempting to use degraded tesamorelin wastes the injection and skews your protocol timeline. Ipamorelin is more stable and can tolerate brief temperature excursions (up to 6 hours at room temperature) without significant potency loss, but prolonged exposure (>12 hours) still causes measurable degradation. The safest rule: if it wasn't refrigerated within 30 minutes of reconstitution or between doses, replace it.

View source ↗
What If IGF-1 Levels Don't Increase After Four Weeks?

Verify injection timing and fasting state first. Post-meal administration is the most common protocol error. If timing is correct, confirm peptide storage integrity (refrigerated continuously, no temperature excursions). IGF-1 non-responders are rare but documented in clinical literature. Approximately 8% of research subjects show blunted IGF-1 response despite confirmed GHRH administration, likely due to genetic variations in GHRH receptor density or downstream signalling pathway polymorphisms.

View source ↗
What If I Feel Nothing After Two Weeks on the Blend — Is My Dosing Wrong?

Likely yes. Subtherapeutic dosing (starting at 500mcg tesamorelin or 100mcg ipamorelin) is the most common error. Research-grade peptides require adequate receptor saturation to produce measurable effects. Underdosing by 50% extends the lag time to noticeable changes from 2–3 weeks to 6–8 weeks. Verify your reconstitution math: a 5mg vial diluted with 5mL bacteriostatic water yields 1mg per 1mL (or 1000mcg per mL). If you're drawing 0.1mL and expecting 1mg, your concentration is off by a factor of ten. The second possibility: you're dosing too close to meals. Ipamorelin requires fasted administration. Dosing within 90 minutes of a meal blunts GH release by 40–60%, making the peptide feel ineffective even at correct doses.

View source ↗
What If I Miss a Bedtime Ipamorelin Dose — Should I Double Up the Next Morning?

No. Never double-dose peptides to compensate for a missed injection. Ipamorelin's ghrelin receptor agonism is dose-dependent but not cumulative. Administering 600mcg in a single morning injection does not replicate the pulsatile GH release pattern of two 300mcg doses separated by 12–14 hours. If you miss the bedtime dose, resume your normal schedule the next morning at the standard dose. Missing one dose in a 12-week cycle (168 total doses) has negligible impact on cumulative IGF-1 elevation. The bigger mistake is trying to 'catch up' by stacking doses, which increases the risk of side effects (joint stiffness, transient hyperglycemia) without proportional benefit.

View source ↗
What If Reconstituted Tesamorelin Was Left Out Overnight?

Any reconstituted peptide exposed to temperatures above 8°C for more than four hours should be discarded. Tesamorelin's 44-amino-acid structure is particularly vulnerable to thermal denaturation. The peptide unfolds and aggregates at room temperature, losing biological activity while remaining visually unchanged. Injecting degraded peptide won't cause harm but produces zero therapeutic effect. If you're uncertain about storage conditions, prepare a fresh vial rather than risk an ineffective cycle week.

View source ↗